Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental | |
| dc.conicet.organizacion | Provincia de Buenos Aires. Hospital Interzonal General de Agudos Gral. San Martin | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental | |
| dc.contributor.author | Belli, Carolina Bárbara | |
| dc.contributor.author | Bestach, Yesica Soledad | |
| dc.contributor.author | Kornblihtt, Laura Inés | |
| dc.contributor.author | Larripa, Irene Beatriz | |
| dc.date.issued | 2013-01 | |
| dc.description.abstract | Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by refractory cytopenia(s) and variable risk of leukemic progression. Cytogenetic analysis is important in day-to-day clinical practice helping to define subgroups of MDS patients who share similarities in the course of the disease. There are recurring aberrations affecting chromosomes 5, 7, 8, and 20. While all of them do not suggest a therapeutic approach, their presence has been considered as a risk indicator since the original international prognostic scoring system (IPSS) was published. The most recent cytogenetic stratifications tried to find the prognostic significance of less frequent alterations which have been longer included in the intermediate group. Moreover, monitoring of karyotype changes is suggested to evaluate cytogenetic response to treatments and the acquisition of new aberrations associated to an unfavorable outcome. This review focuses on different cytogenetic risk stratifications that have been published during the past twenty years and the molecular background of the most relevant chromosomal findings. | es |
| dc.description.fil | Fil: Belli, Carolina Bárbara. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Bestach, Yesica Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Kornblihtt, Laura Inés. Provincia de Buenos Aires. Hospital Interzonal General de Agudos Gral. San Martin; Argentina | |
| dc.description.fil | Fil: Larripa, Irene Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Belli, Carolina Bárbara; Bestach, Yesica Soledad; Kornblihtt, Laura Inés; Larripa, Irene Beatriz; Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes; London Touch Briefing; Oncology & Hematology Review (US); 9; 1; 1-2013; 60-67 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2052-3815 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/78643 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 60-67 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Oncology & Hematology Review (US) | es |
| dc.journal.volume | 9 | es |
| dc.language.iso | eng | es |
| dc.publisher | London Touch Briefing | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.17925/OHR.2013.09.1.60 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://touchoncology.com/prognostic-implications-of-cytogenetic-features-in-myelodysplastic-syndromes/ | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Síndromes Mielodiasplasicos | es |
| dc.subject | Citogenética | es |
| dc.subject | Pronostico | es |
| dc.subject | Cariotipo | es |
| dc.subject.classification | Genética Humana | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.ec494caf-6c23-4e95-a13d-5982b71c1cc3_A.pdf
- Tamaño:
- 85.97 KB
- Formato:
- Adobe Portable Document Format